Authors: Gandolfi, O Bonfante, V Voltattornia, M Dall'Olio, R Poli, A Pietra, C Villetti, G

Citation: O. Gandolfi et al., Anticonvulsant preclinical profile of CHF 3381 Dopaminergic and glutamatergic mechanisms, PHARM BIO B, 70(1), 2001, pp. 157-166

Authors: Villetti, G Bregola, G Bassani, F Bergamaschi, M Rondelli, I Pietra, C Simonato, M

Citation: G. Villetti et al., Preclinical evaluation of CHF3381 as a novel antiepileptic agent, NEUROPHARM, 40(7), 2001, pp. 866-878

Authors: Andreani, A Leoni, A Locatelli, A Morigi, R Rambaldi, M Pietra, C Villetti, G

Citation: A. Andreani et al., 4-aminopyridine derivatives with antiamnesic activity, EUR J MED C, 35(1), 2000, pp. 77-82

Authors: Trabace, L Cassano, T Steardo, L Pietra, C Villetti, G Kendrick, KM Cuomo, V

Citation: L. Trabace et al., Biochemical and neurobehavioral profile of CHF2819, a novel, orally activeacetylcholinesterase inhibitor for Alzheimer's disease, J PHARM EXP, 294(1), 2000, pp. 187-194

Authors: Ghidini, E Delcanale, M Servadio, V Pietra, C Bergamaschi, M Villetti, G Redenti, E Ventura, P Merlini, L

Citation: E. Ghidini et al., Synthesis of a new series of N-hydroxy, N-alkylamides of aminoacids as ligands of NMDA glycine site, EUR J MED C, 34(9), 1999, pp. 711-717

Authors: Pietra, C Villetti, G Bolzoni, PT Delcanale, M Amari, G Caruso, P Civelli, M

Citation: C. Pietra et al., Cholinesterase inhibitory activity of new geneserine derivatives, ALZHEIMER'S DISEASE AND RELATED DISORDERS, 1999, pp. 689-696